MICROBOT MEDICAL INC. (NASDAQ:MBOT) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07 Submission of Matters to a Vote of Security Holders
The Annual Meeting of Stockholders (the “Annual Meeting”) of Microbot Medical Inc. (the “Company”) was held on September 12, 2017. At the Annual Meeting, the stockholders voted on the following five proposals and cast their votes as described below. The proposals are described in more detail in the Company’s Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on August 11, 2017 (the “Proxy Statement”).
| Proposal 1: | Election of the two nominees listed below to serve as Class II Directors on the Board of Directors of the Company until the 2020 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: |
| Name | Number of Votes Cast in Favor | Number of Votes Cast Against | Number of Votes Abstained | Broker Non-Votes |
| Yehezkel (Hezi) Himelfarb | 17,549,147 | 156,046 | 279,200 | 5,358,298 |
| Scott Burell | 17,793,022 | 161,783 | 29,588 | 5,358,298 |
| Proposal 2: | The ratification of Brightman Almagor Zohar & Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as the Company’s independent registered public accounting firm for the year ending December 31, 2017: |
| Number of Votes Cast in Favor | Number of Votes Cast Against | Number of Votes Abstained |
| 22,569,859 | 495,895 | 276,937 |
| Proposal 3. | To approve the Microbot Medical Inc. 2017 Equity Incentive Plan as described in the Proxy Statement: |
| Number of Votes Cast in Favor | Number of Votes Cast Against | Number of Votes Abstained | Broker Non-Votes |
| 14,433,350 | 3,398,721 | 152,322 | 5,358,298 |
| Proposal 4: | To approve the non-binding advisory resolution supporting the compensation of the Company’s named executive officers as described in the Proxy Statement: |
| Number of Votes Cast in Favor | Number of Votes Cast Against | Number of Votes Abstained | Broker Non-Votes |
| 14,408,172 | 3,425,881 | 150,340 | 5,358,298 |
| Proposal 5: | To approve the non-binding advisory resolution regarding the frequency of future non-binding advisory votes related to future named executive officer compensation as described in the Proxy Statement: |
| 3 Years | 2 Years | 1 Year | Abstained | Broker Non-Votes |
| 14,330,310 | 157,478 | 3,422,643 | 73,962 | 5,358,298 |
The Board of Directors of the Company, in light of the vote with respect to Proposal 5 above, determined that the Company will hold a say-on-pay advisory vote every three years.
About MICROBOT MEDICAL INC. (NASDAQ:MBOT)
Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures. Its ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company’s TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.
